Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Mar-23 9:14 AM View:  | Race Geoffrey Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 3,937 | $7.12 | $28,031.40 | (100%) 3.94K to 0 | |
| 09-Mar-23 9:12 AM View: | Bermingham Nessan Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 6,328 | $7.12 | $45,055.40 | (6%) 103.88K to 97.55K | |
| 09-Mar-23 9:16 AM View: | Brewis Neil Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 105,088 | $7.12 | $748,227.00 | (100%) 105.09K to 0 | |
| 09-Mar-23 9:20 AM View: | Forster Eliot President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 347,578 | $7.12 | $2,474,760.00 | (100%) 347.58K to 0 | |
| 09-Mar-23 9:21 AM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 29,236 | $7.12 | $208,160.00 | (100%) 29.24K to 0 | |
| 09-Mar-23 9:18 AM View: | Deptula-Hicks Darlene M See Remarks | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 25,539 | $7.12 | $181,838.00 | (45%) 56.44K to 30.9K | |
| 09-Mar-23 9:17 AM View: | Brady Todd C Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 15,004 | $7.12 | $106,828.00 | (100%) 15.0K to 0 | |
| 09-Mar-23 9:12 AM View: | Benz Edward Jr Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 4,385 | $7.12 | $31,221.20 | (100%) 4.38K to 0 | |
| 09-Mar-23 9:10 AM View: | Arkowitz David Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 8,386 | $7.12 | $59,708.30 | (100%) 8.39K to 0 | |
| 09-Mar-23 9:12 AM View: | Bermingham Nessan Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 97,547 | $7.12 | $694,535.00 | (100%) 97.55K to 0 | |
| 09-Mar-23 9:18 AM View: | Deptula-Hicks Darlene M See Remarks | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 30,898 | $7.12 | $219,994.00 | (100%) 30.9K to 0 | |
| 09-Mar-23 9:16 AM View: | Brewis Neil Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 9,375 | $7.12 | $66,750.00 | (8%) 114.46K to 105.09K | |
| 09-Mar-23 9:20 AM View: | Forster Eliot President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 73,959 | $7.12 | $526,588.00 | (18%) 421.54K to 347.58K | |
| 09-Mar-23 9:21 AM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 25,019 | $7.12 | $178,135.00 | (46%) 54.26K to 29.24K | |
| 02-Aug-22 9:07 PM View: | Brewis Neil Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 29-Jul-22 | Option Exercise | 76,619 | $0.11 | $8,428.09 | 202% 37.84K to 114.46K | |
| 02-Aug-22 9:08 PM View: | Forster Eliot President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 29-Jul-22 | Option Exercise | 260,977 | $0.11 | $28,707.50 | 163% 160.56K to 421.54K | |
| 09-Jan-23 4:04 PM View: | Race Geoffrey Director | F-Star Therapeutics, Inc. (FSTX) | 29-Jul-22 | Option Exercise | 3,937 | $0.11 | $433.07 | 100% 0 to 3.94K | |
| 04-Nov-21 9:34 PM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 02-Nov-21 | Market Sale (Planned) | 64 | $6.83 | $436.84 | (< 1%) 54.32K to 54.26K | (3%) |
| 06-Oct-21 4:38 PM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 04-Oct-21 | Market Sale (Planned) | 64 | $7.23 | $462.44 | (< 1%) 54.38K to 54.32K | (1%) |
| 07-Jul-21 9:13 PM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 02-Jul-21 | Market Sale (Planned) | 1,054 | $8.43 | $8,885.22 | (2%) 55.44K to 54.38K | 9% |
| 02-Feb-21 4:10 PM View: | Benz Edward Jr Director | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 4,385 | -- | -- | 100% 0 to 4.38K | |
| 02-Feb-21 4:29 PM View: | Brewis Neil Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 18,000 | -- | -- | 91% 19.84K to 37.84K | |
| 02-Feb-21 4:26 PM View: | Forster Eliot President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 142,000 | -- | -- | 765% 18.56K to 160.56K | |
| 02-Feb-21 4:06 PM View: | Deptula-Hicks Darlene M Treasurer and CFO | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 30,000 | -- | -- | 113% 26.44K to 56.44K | |
| 02-Feb-21 4:22 PM View: | Kayitalire Louis Chief Medical Officer | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 29,000 | -- | -- | 110% 26.44K to 55.44K | |
| 02-Feb-21 4:17 PM View: | Bermingham Nessan Director | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 87,000 | -- | -- | 516% 16.88K to 103.88K | |
| 23-Nov-20 11:14 AM View: | Driscoll Martin J President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Market Option Sale | 175 | $4.76 | $833.00 | (< 1%) 47.6K to 47.42K | |
| 23-Nov-20 11:10 AM View: | Iyer Radhakrishnan P. Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Market Option Sale | 175 | $4.76 | $833.00 | (< 1%) 137.81K to 137.64K | |
| 23-Nov-20 11:14 AM View: | Winslow Garrett General Counsel and Secretary | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Market Option Sale | 175 | $4.76 | $833.00 | (< 1%) 18.75K to 18.57K | |
| 23-Nov-20 11:12 AM View: | Firmani Lori VP of Finance and Treasurer | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Market Option Sale | 175 | $4.76 | $833.00 | (< 1%) 18.04K to 17.87K | |
| 24-Nov-20 7:00 PM View: | Brewis Neil Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Grant | 19,844 | -- | -- | 100% 0 to 19.84K | |
| 24-Nov-20 7:09 PM View: | Forster Eliot President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Grant | 18,560 | -- | -- | 100% 0 to 18.56K | |
| 23-Nov-20 11:10 AM View: | Iyer Radhakrishnan P. Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Grant | 12,500 | -- | -- | 10% 120.31K to 132.81K | |
| 23-Nov-20 11:14 AM View: | Winslow Garrett General Counsel and Secretary | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 23-Nov-20 11:12 AM View: | Firmani Lori VP of Finance and Treasurer | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Grant | 12,500 | -- | -- | 698% 1.79K to 14.29K | |
| 23-Nov-20 11:14 AM View: | Driscoll Martin J President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Grant | 15,000 | -- | -- | 66% 22.6K to 37.6K | |
| 23-Nov-20 11:10 AM View: | Iyer Radhakrishnan P. Chief Scientific Officer | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Option Exercise | 5,000 | -- | -- | 4% 132.81K to 137.81K | |
| 23-Nov-20 11:14 AM View: | Winslow Garrett General Counsel and Secretary | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Option Exercise | 6,250 | -- | -- | 50% 12.5K to 18.75K | |
| 23-Nov-20 11:12 AM View: | Firmani Lori VP of Finance and Treasurer | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Option Exercise | 3,750 | -- | -- | 26% 14.29K to 18.04K | |
| 23-Nov-20 11:14 AM View: | Driscoll Martin J President and CEO Director | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Option Exercise | 10,000 | -- | -- | 27% 37.6K to 47.6K | |
| 01-Oct-20 4:00 PM View: | Brady Todd C Director | F-Star Therapeutics, Inc. (FSTX) | 30-Sep-20 | Grant | 9,235 | -- | -- | 18% 50.78K to 60.02K | |
| 01-Oct-20 4:00 PM View: | Clackson Timothy P Director | F-Star Therapeutics, Inc. (FSTX) | 30-Sep-20 | Grant | 9,422 | -- | -- | 23% 41.06K to 50.49K | |
| 01-Jul-20 4:00 PM View: | Clackson Timothy P Director | F-Star Therapeutics, Inc. (FSTX) | 30-Jun-20 | Grant | 8,588 | -- | -- | 26% 32.48K to 41.06K | |
| 01-Jul-20 4:00 PM View: | Brady Todd C Director | F-Star Therapeutics, Inc. (FSTX) | 30-Jun-20 | Grant | 8,418 | -- | -- | 20% 42.36K to 50.78K | |
| 01-Apr-20 4:00 PM View: | Clackson Timothy P Director | F-Star Therapeutics, Inc. (FSTX) | 31-Mar-20 | Grant | 13,575 | -- | -- | 72% 18.9K to 32.48K | |
| 01-Apr-20 4:00 PM View: | Brady Todd C Director | F-Star Therapeutics, Inc. (FSTX) | 31-Mar-20 | Grant | 13,306 | -- | -- | 46% 29.06K to 42.36K | |
| 02-Jan-20 5:09 PM View: | Brady Todd C Director | F-Star Therapeutics, Inc. (FSTX) | 31-Dec-19 | Grant | 7,832 | -- | -- | 37% 21.23K to 29.06K | |
| 02-Jan-20 5:17 PM View: | Smith Scott Andrew Director | F-Star Therapeutics, Inc. (FSTX) | 31-Dec-19 | Grant | 12,500 | -- | -- | 50% 24.98K to 37.48K | |
| 02-Jan-20 5:07 PM View: | Arkowitz David Director | F-Star Therapeutics, Inc. (FSTX) | 31-Dec-19 | Grant | 9,098 | -- | -- | 32% 28.83K to 37.93K | |
| 02-Jan-20 5:11 PM View: | Clackson Timothy P Director | F-Star Therapeutics, Inc. (FSTX) | 31-Dec-19 | Grant | 7,991 | -- | -- | 73% 10.91K to 18.9K |
